FDA Approves First Interchangeable Biosimilar for Two Rare Diseases
For Immediate Release: May 28, 2024 Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment …